Here are nine developments from spine devicemakers since Dec. 7:

Several new augmented reality systems for spine and orthopedics went to market in the U.S. or were approved in 2022.

The FDA approved the market's smallest implantable and rechargeable spinal cord stimulation system, designed by healthcare technology company Abbott. 

Spine implant provider Spineart has partnered with surgical navigation company eCential Robotics to open augmented spine surgery training centers in the U.S. and Europe.

Saluda Medical initiated the U.S. commercialization of the Evoke spinal cord stimulator, the devicemaker said Dec. 15.

Surgalign reached 100 cases with the Cortera spinal fixation system, the devicemaker said Dec. 15.

Life Spine's TruLift lateral expandable spacer and lateral plate systems earned FDA 510(k) clearance, the devicemaker said Dec. 14.

Centinel Spine hit the 250th case with the Prodisc C Vico and Prodisc C SK total disc replacement systems, the devicemaker said Dec. 14.

The Dow Jones Sustainability World Index named Medtronic as a world leader in sustainability for the 15th consecutive year.

Medtronic, ZimVie and Zimmer Biomet all saw a decrease in revenue and sales in the second or third quarter of 2022. 

Two orthopedic and spine products were recalled in 2022:

A jury ruled that DePuy Synthes, Johnson & Johnson's orthopedic business, must pay $12 million to RSB Spine for patent infringement.

SyncAR, a spine navigation system co-developed by neurosurgeons at Hoag's Pickup Family Neurosciences Institute, was debuted, the health system said Dec. 7.

From a new intervertebral cage to a new sacroiliac joint fusion device, spinal technology has evolved rapidly in the last year. Here are 16 spinal technology developments from 2022: 

Here are four updates in spine and orthopedic medtech since Nov. 30:

Happe Spine named Andrew Iott as its president and CEO, the devicemaker said Dec. 7.

Jeffrey Carlson, MD, performed the first case with the Align Peek TLIF and PLIF intervertebral cage, his practice said Dec. 6.

In 2022, artificial disc replacement technology has seen significant growth from ongoing research and product developments.

Elon Musk pushed back plans to test the Neuralink brain chip in humans to 2023, The New York Times reported Nov. 30.

Researchers from Plano-based Texas Back Institute supports Centinel Spine's STALIF M portfolio, the devicemaker said Nov. 30.